SCHEMBL18606683

SCHEMBL18606683

Cc1nc(-c2ccccn2)nc(N)c1C

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 5/20 0.58
▸ KDM4E B2RXH2 4/20 0.58
▸ ALOX15 P16050 2/20 0.58
▸ TDP1 Q9NUW8 4/20 0.57
▸ METAP1 P53582 7/20 0.51
▸ METAP2 P50579 4/20 0.51
▸ HTT P42858 4/20 0.49
▸ NPC1 O15118 3/20 0.49
▸ ALDH1A1 P00352 1/20 0.49
▸ RAB9A P51151 1/20 0.49
▸ TP53 P04637 2/20 0.47
▸ MEN1 O00255 1/20 0.47
▸ KMT2A Q03164 1/20 0.47
▸ SMN1; SMN2 Q16637 3/20 0.45
▸ LMNA P02545 3/20 0.45
▸ PPP1CA P62136 2/20 0.45
▸ MAPT P10636 1/20 0.45
▸ NPSR1 Q6W5P4 1/20 0.44
▸ ADORA2A P29274 1/20 0.44
▸ ADORA1 P30542 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16370046 0.91 L3MBTL1 (0.63) L3MBTL1KDM4EALOX15TDP1METAP1
SCHEMBL20665658 0.83 L3MBTL1 (0.54) L3MBTL1KDM4EALOX15TDP1METAP1
SCHEMBL20371378 0.81 KDM4E (0.59) L3MBTL1KDM4EALOX15TDP1METAP1
SCHEMBL11036761 0.80 KDM4E (0.68) L3MBTL1KDM4EALOX15TDP1METAP1
SCHEMBL12143473 0.77 METAP1 (0.73) L3MBTL1KDM4EALOX15TDP1METAP1
SCHEMBL4482806 0.76 L3MBTL1 (0.50) L3MBTL1KDM4EALOX15TDP1METAP1
SCHEMBL16876611 0.76 L3MBTL1 (0.53) L3MBTL1KDM4EALOX15TDP1METAP1
SCHEMBL322756 0.74 KDM4E (1.00) L3MBTL1KDM4EALOX15TDP1METAP1
SCHEMBL29354466 0.74 KDM4E (1.00) L3MBTL1KDM4EALOX15TDP1METAP1
SCHEMBL1704624 0.74 KDM4E (0.76) L3MBTL1KDM4EALOX15TDP1METAP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170071940-A1 Methionine Aminopeptidase Inhibitors for Treating Infectious Diseases TEXAS SOUTHERN UNIVERSITY (US) 2017-03-16 — — US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170071940-A1 Methionine Aminopeptidase Inhibitors for Treating Infectious Diseases METAP1, DNPEP, METAP2 L3MBTL1 1148/4885KDM4E 2771/4885ALOX15 1809/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback